Related Experiment Video
Updated: Jul 19, 2026

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates
Published on: February 23, 2018
Transdermal absorption of radioprotectors using permeation-enhancing vehicles
M Sodicoff1, A Lamperti, M C Ziskin
1Department of Anatomy, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
Topical radioprotectors like WR-2721 can be effectively delivered to the skin using specific vehicles. This research shows that choosing the right formulation enhances radioprotector absorption through the skin
Area of Science:
- Pharmacology and Toxicology
- Dermatology
- Radiation Biology
Background:
- Clinical use of radioprotectors is limited by toxicity and concerns about protecting tumors.
- Topical radioprotection of skin, potentially with WR-2721, is a promising area, but previous studies using water-based solutions were ineffective.
- The stratum corneum presents a significant barrier to topical drug absorption.
Purpose of the Study:
- To investigate the skin absorption of radioprotectors (WR-2721 and cysteine) using various permeation-enhancing vehicles.
- To compare the absorption of radioprotectors in different vehicles versus water.
- To identify optimal vehicles for enhancing radioprotector penetration into and through the skin.
Main Methods:
- Radiolabeled WR-2721 and cysteine were dissolved in vehicles like dimethylformamide (DMF), propylene glycol, 2-pyrrolidone (2-P), methyl-2-pyrrolidone (M-2-P), and dimethylsulfoxide (DMSO).
- Absorption was studied through hairless mouse skin.
- Skin concentrations and plasma levels of the radioprotectors were measured to assess penetration.
Main Results:
- Dimethylformamide (DMF) most effectively increased WR-2721 concentration in the skin.
- Propylene glycol facilitated WR-2721 absorption into the dermis, indicated by plasma levels.
- DMF, 2-pyrrolidone (2-P), and methyl-2-pyrrolidone (M-2-P) improved skin cysteine levels, while dimethylsulfoxide (DMSO) increased plasma cysteine.
- Pre-treatment with DMSO enhanced WR-2721 skin concentration regardless of the vehicle.
- 2-P and DMF significantly increased plasma levels of WR-2721 (10- and 12-fold).
Conclusions:
- The choice of vehicle is critical for overcoming the stratum corneum barrier and enhancing topical radioprotector absorption.
- Specific vehicles like DMF and 2-P can significantly improve the penetration of radioprotectors into all skin layers.
- This approach holds potential for developing effective topical radioprotection strategies.
More Related Videos
Related Concept Videos
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more effectively...
Bioavailability Enhancement: Drug Permeability Enhancement
Transdermal Drug Delivery Systems

